Our results suggest that AAV2 regulated expression and/or stabilization of c-Myc could serve to amplify proliferation signals which allow the breast cancer cells to bypass cell cycle checkpoint controls in the presence of damaged cellular DNA. This evidence concerns the gene MYC and breast carcinoma.